- Home
- DRVN vs FOLD Comparison
DRVN vs FOLD Comparison
Compare DRVN & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRVN
- FOLD
- Stock Information
- Founded
- DRVN 1972
- FOLD 2002
- Country
- DRVN United States
- FOLD United States
- Employees
- DRVN N/A
- FOLD N/A
- Industry
- DRVN Automotive Aftermarket
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- DRVN Consumer Discretionary
- FOLD Health Care
- Exchange
- DRVN Nasdaq
- FOLD Nasdaq
- Market Cap
- DRVN 2.6B
- FOLD 2.9B
- IPO Year
- DRVN 2021
- FOLD 2007
- Fundamental
- Price
- DRVN $16.29
- FOLD $9.64
- Analyst Decision
- DRVN Buy
- FOLD Strong Buy
- Analyst Count
- DRVN 12
- FOLD 8
- Target Price
- DRVN $17.88
- FOLD $16.71
- AVG Volume (30 Days)
- DRVN 568.3K
- FOLD 2.6M
- Earning Date
- DRVN 02-20-2025
- FOLD 02-26-2025
- Dividend Yield
- DRVN N/A
- FOLD N/A
- EPS Growth
- DRVN N/A
- FOLD N/A
- EPS
- DRVN 0.03
- FOLD N/A
- Revenue
- DRVN $2,329,148,000.00
- FOLD $493,671,000.00
- Revenue This Year
- DRVN $4.04
- FOLD $34.33
- Revenue Next Year
- DRVN $7.93
- FOLD $21.70
- P/E Ratio
- DRVN $561.80
- FOLD N/A
- Revenue Growth
- DRVN 1.71
- FOLD 32.58
- 52 Week Low
- DRVN $10.59
- FOLD $9.02
- 52 Week High
- DRVN $17.45
- FOLD $14.57
- Technical
- Relative Strength Index (RSI)
- DRVN 50.71
- FOLD 45.60
- Support Level
- DRVN $15.71
- FOLD $9.62
- Resistance Level
- DRVN $17.01
- FOLD $9.86
- Average True Range (ATR)
- DRVN 0.45
- FOLD 0.33
- MACD
- DRVN -0.11
- FOLD 0.03
- Stochastic Oscillator
- DRVN 41.19
- FOLD 46.30
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.